Synercid
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Introduction We aimed to obtain an in-depth understanding on recent antimicrobial resistance trends and molecular epidemiology…
Aims: Antibiotic residues as well as antibiotic‐resistant bacteria in environmental samples might pose a risk to human health…
The antibiotic release from and the bacteria growth inhibition by antibiotic-loaded acrylic bone cement hip spacers were studied…
Synercid®, a new semisynthetic streptogramin-derived antibiotic containing dalfopristin and quinupristin, is used in treatment of…
ABSTRACT We compared the efficacies of quinupristin-dalfopristin (Q-D; 30 mg/kg of body weight every 8 h) and vancomycin (60 mg…
Synercid (quinupristin/dalfopristin), the first semi-synthetic injectable streptogramin, is a promising alternative to…
Figure 1. Relationship between antimicrobial therapy and blood cultures yielding vancomycin-resistant enterococci (VRE) in a bone…
Quinupristin/dalfopristin (Synercid), the first injectable streptogramin antibiotic available for the treatment of complicated…
ABSTRACT The activities of eight fluoroquinolones and linezolid, quinupristin-dalfopristin (Synercid), gentamicin, and vancomycin…